Click here to view as a pdf!
The Journal of Renal Nutrition is the official
research publication of the Council on Renal Nutrition of
the National Kidney Foundation,
Inc. and the International
Society of Renal Nutrition and Metabolism. The purpose
of JRN is to stimulate interest and research
in nutrition pertaining
to kidney and urologic diseases, hypertension, dialysis
therapies and kidney transplantation in children and
adults, as
well as to publish information concerning renal nutrition
research, practice issues and policies. The goal of JRN
is to
publish original communications and research that maintain
high standards for the profession and that contribute significantly
to the overall advancement of the field.
The JRN is a refereed publication. Manuscripts are
accepted for review with the
understanding that the material
has not been previously published except in abstract form,
and is not concurrently under review for publication
elsewhere.
Authors submitting a manuscript to JRN must understand
that if it is accepted for publication, copyright of the
article
including the right to reproduce the article in all forms
and media, shall be assigned exclusively to the National Kidney
Foundation.
The Publisher, Elsevier, will not refuse any
reasonable request by the author for permission to reproduce
any of his or her contributions
to the Journal. Information on
how to request permission is available on the JRN website
(www.jrnjournal.org).
Manuscript Categories
The Journal of Renal Nutrition welcomes manuscripts in the
following categories: Original
Research Articles, Reviews,
Clinical/Research Briefs, Practical Aspects Articles, Case
Studies, Patient Education Material, Letters to
the Editor,
and Supplements. Authors should adhere to the guidelines
provided for each type of manuscript.
Original Research:
Original research articles are fulllength
reports that cover topics relevant to renal nutrition
dietetics or renal nutrition science
for both adult and pediatric
issues. To be published, the work presented in the manuscript
must be original; on occasion, confirmatory
studies of timely
and important observations will also be acceptable. In addition,
other considerations for evaluating the acceptability
of
a submitted manuscript include its importance, the soundness
of the experimental design, the validity of the methods, the
appropriateness
of the conclusions, and the quality of presentation.
Original Research manuscripts should be organized as
follows: title page, support
and financial disclosure, abstract,
introduction, methods, results, discussion, practical application,
acknowledgments, references, tables,
and legends and
figures. All pages should be numbered consecutively, starting
with the title page as page one. Original Research manuscripts,
in general, should range between 2,500 and 4,000
words, but are typically about 3,500 words, not including references.
Tables and illustrations
range from 2 to 6 and should
be limited to those most pertinent to the study without duplicating
findings in the text. The editor reserves
the right to
publish excessively long tables as online-only material. Failure to comply with length restrictions may result in a delay
in
processing the paper.
Reviews: Comprehensive, quantitative reviews of specific
renal nutrition topics of clinical relevance,
traditional or
meta-analysis, are usually invited contributions; however, letters
of interest are welcomed. Reviews should address topics
with an extensive body of literature to provide a critical summary
of the current evidence and applications. In some cases,
review articles
may also address an emerging topic with limited
literature to better demonstrate the need for more research, but
if the focus of the
article is on a clinical practice issue, this might
better be presented as a "Practical Aspects" article.
Reviews should
include: (1) an unstructured abstract (150
maximum word count) that clearly states the purpose of the
review, the methodology employed,
brief findings and conclusion;
(2) introduction and purpose; (3) body, which
develops the subject in logical order using appropriate
headings
and subheadings; (4) conclusions that specify the needs
for further research; (5) a detailed and comprehensive list of
references;
and (6) relevant tables and/or figures. Maximum
word count for a review article is 4500 words, not including
references, tables/figures
and title page.
Clinical/Research Briefs: Clinical/research briefs are submitted
in an abbreviated manuscript format that
presents clinical
practice experience, preliminary research findings (basic
or clinical), or professional observations in a shortened
report
form. Length usually should not exceed six double-spaced
pages, not including references, tables and figures. Clinical/
Research
Briefs should be organized as follows: title page,
support and financial disclosure, abstract, introduction,
methods, results, discussion,
practical application, acknowledgments,
references, tables, and legends and figures. All
pages should be numbered consecutively, starting
with the
title page as page one.
Practical Aspects: The Journal welcomes manuscripts
about a specific renal nutrition topic
of clinical relevance
for the provider of nutrition or medical care to patients
with kidney disease. Contributions to this section are
detailed
protocols, forms, or other such materials that are successfully
utilized for delivery of nutrition care or medical, nursing
or
psychological care that has a nutrition component.
Material submitted to the Practical Aspects section should
include: (1) a title
page; (2) an unstructured abstract (150
maximum word count); (3) an introduction and purpose;
(4) a body, which develops the subject
in logical order using
appropriate headings and subheadings; (5) references and,
(6) tables and figures, when appropriate.
Case
Studies: This detailed scenario should illustrate
a patient care situation that benefited from nutrition intervention.
Typically,
it should consist of a brief clinical and nutrition
history, and a detailed nutrition intervention plan with
discussion of recommendations
focused on practical application.
Appropriate laboratory values, anthropometric measurements,
and clinical parameters should be provided.
Patient Education*: This section provides renal dietitians
with a convenient, easy-to-read, educational handout for
patient
distribution. Patient education materials are published online only, although they are referenced in the Table of Contents
of the print
edition.
Submissions for Patient Education should be accompanied
by an introduction explaining the rationale for the development
of
the material and, when appropriate, how it should
be used. Text should be clear and concise and illustrations
should be contained on
two pages with expanded type.
Letters to the Editor: Letters should be restricted to scientific
commentary about materials
published in JRN or to topics
of general interest to professionals working in the field of renal
nutrition science and dietetics.
Letters must be double-spaced,
should include a title page, should have no more than 10 references,
and should not exceed 750 words.
All letters will be subjected
to editorial review and decision before acceptance. TheJRN does not accept letters that are unrelated
to a specific,
recently published article; that contain extensive unpublished
data; or that engage in personal slander or invective.
Supplements: The JRN publishes funded supplements after
approval and review by the Editorial Office. Initial inquiries
and proposals for supplements should be directed to Jerrilynn
D. Burrowes, Editor-in-Chief, Journal of Renal Nutrition atjerrilynn.burrowes@liu.edu.
*NOTE: Patient Education and Product Updates are accepted
for publication solely on the JRN website.
They will be listed
in the printed table of contents and indexed in MEDLINE.
There are no charges for color figures; however, they will
be subject to the same copyright laws as the printed edition.
Manuscript Preparation and Submission
The Journal of Renal
Nutrition utilizes the Elsevier Editorial
System (EES), a web-based manuscript submission and peer review
system that provide full
electronic capabilities for
submission, review, and status updates. Manuscripts must
be submitted at
http://ees.elsevier.com/yjren.
Manuscripts
that do not comply with these specific guidelines
will be returned to the authors for revision prior
to being sent out for
review or evaluated by the editors.
Authors should review carefully the Tutorial for Authors, which
can be found at http://support.elsevier.com/app/answers/ detail/a_id/116. After submission, the author can log onto
the EES to view the status of the manuscript. For problems
or questions
concerning submission, contact Sheila Gibbons,JRN Managing Editor at managingeditorjrn@gmail.com orsupport@elsevier.com.
All accepted manuscripts are subject to editorial revision
and shortening. Authors should avoid redundancy between
sections of text
and between illustrations and text. Due to
page limitations, the Editors may decide that tables, illustrations,
appendices, acknowledgments,
and other material
should be published online and referenced in the print edition.
Manuscript Format
Manuscripts must
adhere to standard layout and length
guidelines. Manuscripts must be submitted in Microsoft
Word, double-spaced using 12 pt. font (preferably
Times
New Roman) and unjustified margins. Pages must be numbered
starting with the title page. Include a cover letter to
the Editor with
the submission stating the main aspects of the
research findings of the article. Identify the name of the corresponding
author. The JRN
encourages authors to provide the
names, fields of interest, addresses, telephone and fax numbers,
and e-mail addresses of 3 to 4 unbiased
and qualified potential
expert reviewers from outside the authors' institutions.
Do not use the footnote function for references or
the
comments function. DO NOT UPLOAD MANUSCRIPT
TEXT FILES IN PDF FORMAT. Also, manuscripts must
not be submitted with track changes.
Use of the present tense is preferable. Refer to patients by
number. Actual names or initials should not be used in the
text, tables,
or illustrations. All clinical laboratory values
should be expressed in U.S. conventional units. If necessary,
the International System
of Units (SI units) can be provided
in parentheses immediately after the U.S. convention units.
Conversion tables are available at JAMA
1986; 255(17):
2329-2339 or Ann Intern Med 1987;106(1):114-129.
International authors are advised to have their manuscripts
reviewed by a scientific colleague who is fluent in English so
that the manuscripts will conform to U.S. English usage and
grammar. The
EES has a language editing service available at
http://support.elsevier.com/app/answers/detail/a_id/619/c/ 6261/kw/english%20language.
Manuscript Body
Title Page: The title page should include: (1) the title of
the manuscript; (2) the name and degree(s)
of each author(s);
(3) the current title(s) and affiliation(s) of the author(s);
(4) the corresponding author's name, address, telephone
and
fax numbers, and email address; (5) word counts for the
abstract and the body of the manuscript (excluding, references,
tables and
figures); and (6) a short title (45 characters
or fewer, including spaces) to be used as a running head.
Note: All individuals
listed as authors must fulfill the following
criteria for authorship. Each author must have participated
sufficiently in the work to
take public responsibility for
the content of the paper and must approve of the final version
of the manuscript. Authorship should be
based on substantive
contributions to each of the following: (1) conception and
design of the study; (2) generation, collection, assembly,
analysis
and/or interpretation of data; (3) drafting and/or revision
of the manuscript; and (4) approval of the final version of the
manuscript. The author who is named as the corresponding
author on the manuscript's title page must be the individual
to whom all Editorial-related
correspondence is directed.
Support and Financial Disclosure Declaration: The second
page of each manuscript should acknowledge
research support
(from funding agencies or industry) and disclose any
potential financial conflicts of interest for each author. Any
meaningful affiliation or involvement, either direct or indirect,
with any organization or entity with a direct financial
interest in
the subject matter or materials discussed (e.g.,
employment, consultancies, grants, honoraria) must be disclosed.
Specifics of the disclosure
will remain confidential.
If deemed appropriate by the Editor, a general statement
regarding disclosure will be included in the Acknowledgment
section of the manuscript. The Acknowledgment section
must also reveal all sources of support for the work, both
financial and material.
If no financial conflict of interest is
identified, 'none' should be written next to the author's
name. Note: If the manuscript
is accepted for publication,
a summary of the relevant information will be transferred to
the "Support" and "Financial Disclosure" sections
of the
Acknowledgements.
Abstract: The abstract page should include the title of the
manuscript, but no other identifying
information. A structured
abstract format should be used for "original research"
and "clinical/research brief " using the following headings:
(1) Objective: clear statement of purpose of study; (2) Design:
research design; (3) Setting: context in which the study was
conducted;
(4) Subjects: demographics, selection criteria, control
group used; (5) Intervention: methodology, description of
treatment used; (6)
Main outcome measure: variable used to assess
intervention effect; (7) Results: primary findings of the study;
and (8) Conclusion: brief
summary of the results directly supported
by evidence. The abstract limit is 300 words or fewer.
A list of approximately five keywords
(to be used for indexing)
should appear at the end of the abstract.
Original Research Sections:
- Introduction: Clearly state the purpose of the research. Summarize the rationale and background for the study or observation; cite only pertinent references. The "Introduction" should be limited to 1.5 typed manuscript pages.
- Methods: Provide sufficient detail so that the study can
be repeated. Describe new methods in detail; report
accepted methods briefly with references. Use subheadings
as needed for clarity.
-
Use of Trade Names: Trade names are to be avoided in
defining products whenever possible. If naming
a product trade
name cannot be avoided, the trade
names of other like products should also be mentioned,
and first use should be accompanied by the
superscript
symbol ™ or ®, followed in parentheses
by the owner's name. If a product trade name is used,
it is imperative that the product
be described in sufficient
detail so that professionally trained readers
can understand the nature of the product.
The mention of critical, especially novel, supplies and pieces of equipment ought to be followed, in parenthesis, by name of manufacturer or provider, and on the first mention only, city, state/province, and country (such as Ross Products, Columbus, OH).
Statistics: Describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (e.g., CIs, SDs, or SEs), even for differences that were not significant. Report the number of observations. Specify any general use computer programs used, including the version number and the manufacturer's name and location. Include general descriptions of statistical methods in the "Methods" section and specific descriptions in each table and figure legend. Indicate whether variables were transformed for analysis. Provide details about what hypotheses were tested, what statistical tests were used, and what the outcome and explanatory variables were (where appropriate). Indicate the level of significance used in tests if different from the conventional 2-sided 5% alpha error and whether or what type of adjustment was made for multiple comparisons. When data are summarized in the "Results" section, specify the statistical methods used to analyze them.
-
Use of Trade Names: Trade names are to be avoided in
defining products whenever possible. If naming
a product trade
name cannot be avoided, the trade
names of other like products should also be mentioned,
and first use should be accompanied by the
superscript
symbol ™ or ®, followed in parentheses
by the owner's name. If a product trade name is used,
it is imperative that the product
be described in sufficient
detail so that professionally trained readers
can understand the nature of the product.
- Results: Present the results in a logical sequence in the text, tables, and figures. Do not duplicate data from tables or figures in the text; emphasize or summarize only important observations. Do not present data from individual subjects except for very compelling reasons.
- Discussion: This section should not exceed 4 typewritten pages. Emphasize concisely the novel and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material presented in the "Introduction" or "Results." Compare results to those previously reported. Link conclusions with the goals of the study and avoid unqualified statements and conclusions that are not completely supported by the data. Indicate what new information is contributed by the present study.
- Practical Application: This section is written in terms that the practicing clinician can understand and the potential clinical application of the research presented in the paper. Keep the description short, about 2 to 3 sentences, and in a language that the readers can easily understand. Do not make unreasonable claims that cannot be derived from the work described in the paper. If this section is not included with the manuscript submission, the author acknowledges that an Associate Editor of the Journal will write the practical application of the research findings.
Acknowledgments: If authors wish to express thanks or acknowledge assistance, an acknowledgements section should be inserted after the manuscript text and before the reference list. All individuals who contributed to the writing of the manuscript but who do not qualify as authors must be named in this section. Authors are responsible for informing all listed individuals/parties that they are being mentioned in the manuscript and for obtaining their approval prior to publication.
References
References must be numbered according to order of appearance in the text using superscript numbers in the text. References should be compiled at the end of the manuscript according to the order of citation in the text and should follow the American Medical Association (AMA) style and format. Examples of the most common reference types are provided below. Authors using reference-managing software such as EndNote or Reference Manager should select NLM/PubMed output style.
References should be typed, double-spaced starting on a separate page at the end of the manuscript. When listing references, abbreviate names of journals as listed in PubMed. List all authors and/or editors up to 6; if more than 6, list the first 3 followed by "et al." Journal references should include the issue number in parentheses after the volume number. Accuracy of reference information is the author's responsibility. Please indicate if the source is a complete article, abstract, or editorial; give inclusive page numbers for complete articles. All reference information must be complete when the manuscript is submitted.
Examples of References
Journal Article: Six or Fewer Authors
Eyre S, Attman P, Haraldsson B. Positive effects of protein restriction in patients with chronic kidney disease. J Ren Nutr. 2008;18(3):269-280.
Journal Article: More Than Six Authors
Fernandez-Reyes MJ, Sanchez R, Garcýa L, et al. Acute responses of gastrointestinal hormones to both oral and parenteral intradialytic nutrition. Am J Nephrol. 2010;32(3):272-278.
Journal Article in Press
Steiber AL, Kopple JD. Vitamin status and needs for people with stage 3-5 chronic kidney disease. J Ren Nutr. (in press)
Complete Book
Byham-Gray LD, Burrowes JD, Chertow GM, eds. Nutrition in Kidney Disease. Totowa, NJ: Humana Press; 2008.
Chapter in Book
Wilkens KG, Juneja V. Medical nutrition therapy for renal disorders. In: Mahan LK, Escott-Stump S, eds. Krause's Food & Nutrition Therapy. 12th ed. St. Louis, MO: Saunders; 2008:921-958.
Journal Article in a Supplement
Gullett NP, Hebbar G, Ziegler TR. Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. Am J Clin Nutr. 2010;91(4)(suppl):S1143-S1147.
PubMed Abstract Citation
Szklarek-Kubicka M, Fijalkowska-Morawska J, Zaremba- Drobnik D, Ucinski A, Czekalski S, Nowicki M. Effect of intradialytic intravenous administration of omega-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study [abstract]. J Ren Nutr. 2009;19(6):487-493. http://www.ncbi.nlm.nih. gov/pubmed/19616450. Accessed December 24, 2010. PMID: 19616450.
Editorial
McCarron DA, Drueke TB, Stricker EM. Science trumps politics: urinary sodium data challenge US dietary sodium guideline [editorial]. Am J Clin Nutr. 2010;92 (5):1005-1006.
EPub Ahead of Print
Kagoma YK, Weir A, Iansavichus AV, et al. Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review [published online ahead of print December 9 2010]. Am J Kidney Dis. 2010. http://www.ncbi.nlm.nih.gov/pubmed/ 21146269. Accessed December 24, 2010.
Tables and Figures
Tables: Type each table on a separate page. Do not insert vertical lines in tables. Include a title for each table. Number tables consecutively within the manuscript (Table 1, Table 2, Table 3, etc.). Use standard citation superscript symbols (*,†, ‡, §...). Authors should place footnotes in order, reading from left to right and top to bottom, and should begin a new series of footnotes for each table. Footnotes should not appear in table titles.
Figures: Illustrations include charts, drawings, graphs, and photographs. Charts, drawings and graphs must be computer generated. Each figure should be on a separate page. Number figures consecutively in the order they are to appear in the text (e.g., Figure 1, Figure 2, Figure 3, etc.). Figures should be uploaded as separate files, not embedded in the manuscript file. For most types of figures, TIFF or EPS files are the preferred format. The resolution for line art must be at least 1200 dpi; photographs and shaded drawings must have a finished resolution of 300 dpi. The following image file formats are not acceptable because they are low resolution: PowerPoint, JPG, GIF,ONG, PCX, PNG, XBM, and Excel. On a separate page, list the legend for each figure, double-spaced, with abbreviations and symbols identified.
Authors must bear all costs associated with printed color figures and tables. The cost of the first color figure is$650.00 and each additional figure is $100.00. If authors elect not to print figures in color, in most cases, authors will be able to have their color figures produced in black and white for the print version of JRN, but the figures will appear in color online.
If any table or figure has been published previously, a copy of the letter of permission from the copyright holder must accompany the manuscript. The original source of the table or figure should be acknowledged in full reference form in the reference section of the manuscript. The figure legend (or table notes) should conclude with: "Reprinted with permission" followed by the appropriate reference number. Authors are responsible for applying for permission for both print and electronic rights for all borrowed materials, and they are responsible for paying any fees related to the application of these permissions.
Abbreviations and Acronyms
Complex terms used frequently in the manuscript may be abbreviated. Abbreviations should be placed in parentheses at first use in the abstract and again at first use in the text. Do not use abbreviations and acronyms in titles.
Supplementary Material for Online Publication
Authors may submit supporting material to accompany their article for online-only publication when there is insufficient space to include the material in the print article. This material should be important to the understanding and interpretation of the paper and should not repeat material in the print article. The amount of online-only material should be limited and justified. Online-only material should be original and not previously published.
Online-only material will undergo editorial and peer review with the main manuscript. If the manuscript is accepted for publication and if the editors deem the online only material appropriate for publication, it will be posted online at the time of publication of the article as additional material provided by the authors. The authors are responsible for the accuracy and presentation of all such material.
Online-only material should be submitted in a separate Word document, PDF file, Excel File, Approved Figure format, etc with pages numbered consecutively. Each element included in the online-only material should be cited in the text of the main manuscript (e.g., see Table S1) and numbered in order of citation in the text (e.g., Table S1, Table S2, Figure S1, Figure S2, Appendix S1, etc.). The first page of the online-only document should list the number and the title of each element included in the document.
Online-Only References: All references cited within the online-only document must be included in a separate reference section, including those that also were cited in the main manuscript. They should be formatted just as in the main manuscript and numbered and cited consecutively in the online-only material.
Manuscript Processing and Review Submissions
The JRN Editorial Office receives hundreds of manuscripts a year. Each new manuscript receives a unique number, and information on the manuscript is recorded in the EES. The editorial staff releases information on manuscripts to authors only. The EES will e-mail a letter to the corresponding author acknowledging receipt of a manuscript, whether new or a resubmission.
Review Process
All submissions are sent to peer reviewers. The identities of both the peer reviewers and the authors are kept confidential. Each manuscript is assigned to an Editor who has expertise in the subject area. After review by the Editor, if the manuscript is judged to be appropriate and competitive for publication inJRN, it is sent to at least two experts in the appropriate area for peer review who remain anonymous. The reviewers evaluate each article on the basis of content, originality, scientific accuracy, clarity, and contribution to the field of renal nutrition dietetics and science.
The review process generally takes about 2 to 3 months. Reviewers provide comments for the editor and for the authors. Minor changes in style and clarity are made at the discretion of the reviewers. All substantial changes will require the approval of the author before typesetting.
The Journal expects reviewers to treat manuscripts as confidential communications and not to use the content for their own purposes or make copies of the manuscripts. Reviewers are also expected to declare to the editor any possible conflicts of interest. After peer review (usually 4 to 6 weeks after the date of submission), the corresponding author will be notified whether the manuscript has been accepted, requires revision, or rejected.
Decisions
The single most important criterion for acceptance is the originality of the work. However, a decision to accept a manuscript is not based solely on the scientific validity of its content. Other factors affecting decisions include the extent and importance of new information in the paper compared with that in other papers being considered, the Journal's need to represent a wide range of topics, and the overall suitability for JRN. Decision letters usually, but not always, convey all factors considered for a particular decision. Occasionally, the comments to the authors may appear to be inconsistent with the editorial decision, which takes into consideration reviewers' comments to the editor, as well as the additional factors listed above.
Revisions and Rejections
Manuscript revisions should be resubmitted within three months of the initial decision; they are carefully re-examined by the editorial team and/or reviewers. However, no guarantee can be made about the final acceptability of the paper. If authors of a rejected manuscript are able to make new advances that go far beyond the original submission, they may consider submitting the manuscript again as a new submission, referring to the original submission in the cover letter.
After Acceptance
Accepted manuscripts are sent to the publisher, Elsevier. Once an article has been copyedited, typeset, and authors have reviewed the proof and submitted corrections, the author-corrected proof will be uploaded to the JRN websites (www.jrnjournal.org and www.sciencedirect.com) under "Articles in Press" for pre-print viewing by subscribers. The corrected proof of the article is also delivered to PubMed for indexing. When the article is assigned to a specific issue of JRN, it moves from the Articles in Press section to the table of contents of that issue.
Copyright Transfer
The Copyright will be assigned exclusively to the National Kidney Foundation, including the right to reproduce the article in all forms and media. Authors must sign the copyright transfer agreement.
Copyediting
Manuscripts are copyedited to make them consistent with the Journal style; if a particular section in the manuscript is not clear or requires additional information, the copy editor will direct questions to the author. These questions, or "author queries," will appear in the margins of the proofs that are sent to the author. Changes made by the copy editors for style, grammar, and readability should not be altered by the author(s) unless a scientific error has been introduced.
Proofs
The corresponding author can expect one set of page proofs in PDF format via e-mail approximately two months after acceptance. The PDF proofs can be annotated using Adobe Reader. Instructions on how to annotate PDF files will accompany the proofs. If the author(s) do not wish to use the PDF annotations function, the corrections can be listed (including replies to the Query Form) and returned to Elsevier via email. Please list corrections quoting line number. If, for any reason, this is not possible, the corrections and any other comments can be sent (including replies to the Query Form) on a printout of the proof and returned by fax, scan or e-mail.
Please only check the typesetting, editing, completeness and correctness of the text, tables and illustrations. Significant changes to the article after it has been accepted for publication will only be considered at this stage with permission from the Editor.We will do everything possible to get your article published quickly and accurately. Therefore, it is important to ensure that all corrections are returned to Elsevier in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely the authors' responsibility. Note: With permission from the Editor, Elsevier may proceed with the publication of the article if the proofs are not returned.
Authors are expected to review proofs promptly (within 48 hours of receipt).
Reprints
The corresponding author will be provided with a PDF file of the article via e-mail at no cost. Forms for ordering print article reprints will be sent with the proofs to the authors and should be returned with the corrected proofs. An order form with pricing information will be sent to the corresponding author.
Revised January 1, 2011